Effect of microRNA-21 blockade in human triple negative breast cancer allografts on progression and immune checkpoint proteins

被引：0
|
作者：
Jin, Yuan-Yuan
Desai, Vilas Shivaji
Castro, Miguel M.
Mitchell, Edith P.
Wickstrom, Eric
机构：
[1] Bound Therapeut LLC, Cherry Hill, NJ USA
[2] Thomas Jefferson Univ, Philadelphia, PA USA
[3] Biosynthesis Inc, Lewisville, TX USA
[4] Thomas Jefferson Univ, Sidney Kimmel Canc Ctr, Philadelphia, PA USA
[5] Sidney Kimmel Canc Ctr, Philadelphia, PA USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2023年 / 41卷 / 16期
基金：
美国国家卫生研究院;
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e13097
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Immune checkpoint blockade in triple negative breast cancer influenced by B cells through myeloid-derived suppressor cells
    Alyssa Vito
    Omar Salem
    Nader El-Sayes
    Ian P. MacFawn
    Ana L. Portillo
    Katy Milne
    Danielle Harrington
    Ali A. Ashkar
    Yonghong Wan
    Samuel T. Workenhe
    Brad H. Nelson
    Tullia C. Bruno
    Karen L. Mossman
    Communications Biology, 4
  • [32] Nanodroplet-enhanced sonodynamic therapy potentiates immune checkpoint blockade for systemic suppression of triple-negative breast cancer
    Wu, Wenxin
    Xu, Ming
    Qiao, Bin
    Huang, Tongyi
    Guo, Huanling
    Zhang, Nan
    Zhou, Luyao
    Li, Manying
    Tan, Yang
    Zhang, Minru
    Xie, Xiaoyan
    Shuai, Xintao
    Zhang, Chunyang
    ACTA BIOMATERIALIA, 2023, 158 : 547 - 559
  • [33] Future of checkpoint blockade in triple-negative breast cancer: combination strategies to lead the way
    Telli, M. L.
    Vinayak, S.
    ANNALS OF ONCOLOGY, 2019, 30 (03) : 347 - 348
  • [34] Our experience with immune checkpoint inhibitors in triple-negative breast cancer patients
    Nishio, Minako
    Kojitani, Yoshiki
    Kitashiro, Saya
    Ishiduka, Yasunobu
    Otsuka, Tomoyuki
    Nishida, Naohiro
    Fujisawa, Fumie
    Sugimoto, Naotoshi
    Yagi, Toshinari
    Souma, Ai
    Kanaoka, Haruka
    Oyamayama, Yuri
    Taniguchi, Azusa
    Nakajima, Satomi
    Seto, Yukiko
    Kusama, Hiroki
    Watanabe, Noriyuki
    Matsui, Saki
    Nakayama, Takahiro
    Kudou, Toshihiro
    ANNALS OF ONCOLOGY, 2023, 34 : S1465 - S1465
  • [35] HDAC inhibition modulates immune checkpoint pathway in triple-negative breast cancer
    Barberio, Manuela Terranova
    Thomas, Scott
    Ali, Niwa
    Pawlowska, Nela
    Park, Jeenah
    Rosenblum, Michael D.
    Budillon, Alfredo
    Munster, Pamela N.
    CANCER IMMUNOLOGY RESEARCH, 2018, 6 (09)
  • [36] Immune Checkpoint Inhibitors in Triple Negative Breast Cancer Treatment: Promising Future Prospects
    Thomas, Remy
    Al-Khadairi, Ghaneya
    Decock, Julie
    FRONTIERS IN ONCOLOGY, 2021, 10
  • [37] The Evolving Role of Immune Checkpoint Inhibitors in the Treatment of Triple-Negative Breast Cancer
    Steiner, Meghan
    Tan, Antoinette R.
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2021, 19 (05) : 305 - 315
  • [38] Immune checkpoint inhibition in early-stage triple-negative breast cancer
    Varma, Revati
    Wright, Matthew
    Abraham, Jame
    Kruse, Megan
    EXPERT REVIEW OF ANTICANCER THERAPY, 2022, 22 (11) : 1225 - 1238
  • [39] Window of opportunity trials with immune checkpoint inhibitors in triple-negative breast cancer
    Quintana, A.
    Saini, K. S.
    Vidal, L.
    Peg, V.
    Slebe, F.
    Loibl, S.
    Curigliano, G.
    Schmid, P.
    Cortes, J.
    ESMO OPEN, 2024, 9 (10)
  • [40] The emerging role of immune checkpoint inhibitors in the treatment of triple-negative breast cancer
    Singh, Sima
    Numan, Arshid
    Maddiboyina, Balaji
    Arora, Saahil
    Riadi, Yassine
    Md, Shadab
    Alhakamy, Nabil A.
    Kesharwani, Prashant
    DRUG DISCOVERY TODAY, 2021, 26 (07) : 1721 - 1727
12345